Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hyperglycemia × Vildagliptin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 Breast 1

Conditions

Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Hyperglycemia 1 Diabetes Mellitus, Type 2 1 Breast Neoplasms 1

Interventions

Insulin Glargine 2 Insulin 2 ziprasidone 1 relacorilant 1 pembrolizumab 1 exemestane 1 Vildagliptin 1 Tamoxifen 1 Olanzapine 1 Metformin 1 Letrozole 1 Insulin Lispro 1 Injections 1 Fulvestrant 1 DNA, Ribosomal 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04300790 2025-07-29

METALLICA

MedSIR

Phase 2 Completed

BreastEndocrine

Breast Neoplasms, Hyperglycemia, Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡